On this page
SAMHD1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
The SAMHD1 gene provides instructions for an enzyme crucial in regulating cellular deoxynucleoside triphosphate (dNTP) levels, essential for DNA replication, repair, and immune responses against viruses. The SAMHD1 gene encodes an enzyme that regulates the cellular pool of deoxynucleoside triphosphates (dNTPs), which are fundamental building blocks for DNA.
SAMHD1 is located on the long (q) arm of chromosome 20, at band 20q11.23. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 20 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The SAMHD1 gene, fully named SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, is essential for maintaining cellular health. It encodes an enzyme that performs a critical role in nucleotide metabolism, particularly affecting the availability of deoxynucleoside triphosphates (dNTPs).
Proper function of the SAMHD1 enzyme is crucial for DNA replication, repair, and the body's immune response to viral infections. Inherited changes within the SAMHD1 gene can lead to various health issues, including neurodevelopmental disorders.
What the gene does
The SAMHD1 gene produces an enzyme that acts as a deoxynucleoside triphosphate triphosphohydrolase. This enzyme's primary function is to hydrolyse deoxynucleoside triphosphates (dNTPs) into their deoxynucleoside and triphosphate components. dNTPs are vital for synthesising and repairing DNA within cells.
By controlling the concentration of dNTPs, the SAMHD1 enzyme helps regulate the cellular environment. This regulatory role is important for ensuring sufficient dNTPs for normal cellular processes while also limiting their availability for invading viruses, such as HIV, which require dNTPs to replicate. Beyond its role in dNTP metabolism, the SAMHD1 enzyme is also thought to contribute to DNA repair pathways and the overall stability of genetic material.
Video: Genetics 101
Chromosome location
The SAMHD1 gene is located on chromosome 20, specifically at position 20q11.23. This chromosomal address indicates its precise band on the long arm of chromosome 20. The gene spans a region that encodes the instructions for the SAMHD1 protein, which is 626 amino acids long.
Protein structure
The SAMHD1 protein consists of several distinct regions critical for its function. It features a Disordered region at its N-terminus, spanning amino acids 1-36. Following this is the SAM (Sterile Alpha Motif) Domain, located between amino acids 45 and 110, which is often involved in protein-protein interactions. A significant catalytic region is the HD (His-Asp) Domain, found from amino acids 164 to 316, which contains motifs characteristic of hydrolase enzymes.
Key variants
Variants within the SAMHD1 gene can alter the protein's structure or function, leading to impaired dNTP regulation and other cellular dysfunctions. These genetic changes can vary in type, including single nucleotide changes, insertions, or deletions. The clinical impact of a SAMHD1 variant depends on its specific effect on the protein's activity, which can range from mild to severe alterations in function.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1062+1G>T | - | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi-Goutieres syndrome 5 |
c.1436del | p.Glu479fs | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi Goutieres syndrome |
c.145C>T | p.Gln49Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi-Goutieres syndrome 5 |
c.1512_1513del | p.Met505fs | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi Goutieres syndrome |
c.1584del | p.Ala529fs | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi Goutieres syndrome |
c.626-1G>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi-Goutieres syndrome 5 |
c.664_673del | p.Ile222fs | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi-Goutieres syndrome 5 |
c.703C>T | p.Gln235Ter | Pathogenic | ★★☆☆ | Chilblain lupus 2 |
c.861T>A | p.Tyr287Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi-Goutieres syndrome 5 |
c.944_945dup | p.Phe316fs | Pathogenic/Likely pathogenic | ★★☆☆ | Aicardi-Goutieres syndrome 5 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the SAMHD1 gene are associated with several inherited conditions, most notably Aicardi-Goutières syndrome. This severe neurological disorder is characterised by brain dysfunction, skin lesions, and other health complications. Research suggests that SAMHD1 variants can impair the enzyme's ability to properly regulate dNTP levels, contributing to the development of such conditions.
UK clinical status
SAMHD1 is recognised within the UK's NHS Genomic Medicine Service due to its clinical relevance. It is included on several NHS England's National Genomic Test Directory panels, such as those for Cerebral vascular malformations, Inherited white matter disorders, and Aicardi-Goutières syndrome. Its presence on panels like DDG2P and for Early onset or syndromic epilepsy highlights its association with developmental disorders and neurological conditions.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the SAMHD1 protein?
The SAMHD1 protein primarily functions as an enzyme that breaks down deoxynucleoside triphosphates (dNTPs), which are crucial for DNA synthesis and repair. This activity helps regulate the cellular dNTP pool, important for genomic stability and antiviral defence.
Which condition is most commonly associated with SAMHD1 gene variants?
Variants in the SAMHD1 gene are most notably associated with Aicardi-Goutières syndrome, a severe inherited neurological disorder. This condition can lead to significant brain dysfunction and other systemic issues.
How does SAMHD1 contribute to viral defence?
SAMHD1 contributes to viral defence by reducing the cellular pool of deoxynucleoside triphosphates (dNTPs). This action starves invading viruses, like HIV, of essential building blocks needed for their replication, thereby limiting viral spread.
References
- Livingston JH, Crow YJ. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond. Neuropediatrics. 2016. PMID: 27643693
- Kretschmer S, Wolf C, König N. SAMHD1 prevents autoimmunity by maintaining genome stability. Annals of the rheumatic diseases. 2015. PMID: 24445253
- Crow YJ, Chase DS, Lowenstein Schmidt J. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. American journal of medical genetics. Part A. 2015. PMID: 25604658
- Crow YJ. Aicardi-Goutières syndrome. Handbook of clinical neurology. 2013. PMID: 23622384
- Franzolin E, Pontarin G, Rampazzo C. The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 2013. PMID: 23858451
- Sze A, Olagnier D, Lin R. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection. Journal of molecular biology. 2013. PMID: 24161438
- Rice GI, Forte GM, Szynkiewicz M. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. The Lancet. Neurology. 2013. PMID: 24183309
- Dale RC, Gornall H, Singh-Grewal D. Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures. American journal of medical genetics. Part A. 2010. PMID: 20358604
- Rice GI, Bond J, Asipu A. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nature genetics. 2009. PMID: 19525956
- Crow YJ, Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Human molecular genetics. 2009. PMID: 19808788
- Adam MP, Bick S, Mirzaa GM. Aicardi-Goutières Syndrome. 1993. PMID: 20301648